Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease [7] (multiple letters)

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 510-511

  Clarke, C E ^a   Sato, Y ^a,b,c,d   Asoh, T ^a,b,c,d   Metoki, N ^a,b,c,d   Satoh, K ^a,b,c,d  

^a CITY HOSPITAL   (United Kingdom)

^b Mitate Hospital   (Japan)

^c Futase Social Insurance Hospital   (Japan)

^d HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; METHYLPREDNISOLONE; PARKIN;

DISEASE DURATION; DRUG PULSE THERAPY; DRUG WITHDRAWAL; DYSKINESIA; FATALITY; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INCIDENCE; JAPAN; LETTER; MENTAL DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; ON OFF PHENOMENON; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE;

ANTIPARKINSON AGENTS; HUMANS; INCIDENCE; JAPAN; METHYLPREDNISOLONE; NEUROLEPTIC MALIGNANT SYNDROME; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 1542407281     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)